Menu
Login
Home
(current)
Recurring Events
CE Calendar
Evaluations
Enduring Materials
Live Events
CE Applications
Links
Login
Enduring Material
Biosimilars in Dermatology Review
View Activity Info
Enter Basic User Info
Take Post Test
Create Account
Done
View Activity Info
Continue to Enduring Material
1800 Diagonal Road, Suite 360
Alexandria, VA 22314
General Information
Active Dates
Wednesday, December 6, 2023 - Friday, December 6, 2024
Estimated Completion Time
60 minutes
Conference Host
National Psoriasis Foundation
Conference Location
Virtual Conference Room
Conference Name
Journal of Psoriasis and Psoriatic Arthritis
Provider
National Psoriasis Foundation
Link to Content
-
https://journals.sagepub.com/doi/abs/10.1177/24755303231212154
Watch this Lecture Remotely
Objectives
Event Objectives
Gain better understanding of biosimilars in dermatology
Presentations and Speakers
Biosimilars in Dermatology Review
Bruce Strober, MD
Available Credits/Points
Credit Designation
The National Psoriasis Foundation designates this enduring material for a maximum of 1
AMA PRA Category 1 Credit
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Description
Learn more about biosimilar basics and the experience with biosimilars used in dermatology in the US, Asia, and Europe.
Disclosure Statements
Series Disclosures
Bruce Strober, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
AbbVie, Almirall, Amgen, Arcutis, Arena, Aristea, Asana, Boehringer Ingelheim, Immunic Therapeutics, Bristol Myers Squibb, Connect Biopharma, Dermavant, Eli Lilly, Equillium, GlaxoSmithKline, Janssen, LEO Pharma, Maruho, Meiji Seika Pharma, Mindera, Novar - Consulting - Relationship Has Not Ended
AbbVie, Eli Lilly, Janssen, and Sanofi-Genzyme - Speaking - Relationship Has Not Ended
CorEvitas Psoriasis Registry - co-scientific director - Relationship Has Not Ended
AbbVie, Cara Therapeutics, the CorEvitas Psoriasis Registry, Dermavant, Dermira, and Novartis - investigator - Relationship Has Not Ended
Journal of Psoriasis and Psoriatic Arthritis - editor-in-chief - Relationship Has Not Ended
Sam Koons, NPF Staff, has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
BMS - Consulting - Relationship Has Ended
Event Disclosures
Speakers:
Bruce Strober, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
AbbVie, Almirall, Amgen, Arcutis, Arena, Aristea, Asana, Boehringer Ingelheim, Immunic Therapeutics, Bristol Myers Squibb, Connect Biopharma, Dermavant, Eli Lilly, Equillium, GlaxoSmithKline, Janssen, LEO Pharma, Maruho, Meiji Seika Pharma, Mindera, Novar - Consulting - Relationship Has Not Ended
AbbVie, Eli Lilly, Janssen, and Sanofi-Genzyme - Speaking - Relationship Has Not Ended
CorEvitas Psoriasis Registry - co-scientific director - Relationship Has Not Ended
AbbVie, Cara Therapeutics, the CorEvitas Psoriasis Registry, Dermavant, Dermira, and Novartis - investigator - Relationship Has Not Ended
Journal of Psoriasis and Psoriatic Arthritis - editor-in-chief - Relationship Has Not Ended
Commercial Support
This activity is supported by educational grants from Novartis.
Accreditation Statement
The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Test Information
Percentage of Correct Responses Required to Pass
0 %
Percentage of Responses Required to Submit
100 %
Last Review Date
12/6/2023
Continue to Enduring Material
Powered By
eeds Privacy and Registration Refund Policy
|
eeds Accessibility Statement